|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0087111,
umls-concept:C0205210,
umls-concept:C0282554,
umls-concept:C0524910,
umls-concept:C0871261,
umls-concept:C1274040,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1882417,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-1-30
|
|
pubmed:abstractText |
CCR5Delta32, a 32-base pair deletion of the CC chemokine receptor (CCR) 5 gene, is associated with slowed human immunodeficiency virus disease progression in heterozygotes and protection against infection in homozygotes. A recent study found a higher than expected frequency of CCR5Delta32/Delta32 in patients with hepatitis C virus infection. The roles of other disease-associated chemokine system polymorphisms have not been evaluated in hepatitis C virus infection.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/CCR2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL5,
http://linkedlifedata.com/resource/pubmed/chemical/Interferons,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR5,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Chemokine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
pubmed-author:AlterHarvey JHJ,
pubmed-author:GhanyMarcM,
pubmed-author:GonzalezCarlos MCM,
pubmed-author:HellerTheoT,
pubmed-author:HoofnagleJay HJH,
pubmed-author:KleinerDavid EDE,
pubmed-author:KoziolDeloris EDE,
pubmed-author:LiangT JakeTJ,
pubmed-author:McDermottDavid HDH,
pubmed-author:MerrellMayaM,
pubmed-author:MurphyPhilip MPM,
pubmed-author:ParkYoonY,
pubmed-author:PromratKittichaiK,
pubmed-author:SozaAlejandroA,
pubmed-author:WainbergA SAS
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
124
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
352-60
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12557141-Adult,
pubmed-meshheading:12557141-Aged,
pubmed-meshheading:12557141-Alanine Transaminase,
pubmed-meshheading:12557141-Alleles,
pubmed-meshheading:12557141-Antiviral Agents,
pubmed-meshheading:12557141-Chemokine CCL5,
pubmed-meshheading:12557141-Cohort Studies,
pubmed-meshheading:12557141-Disease Progression,
pubmed-meshheading:12557141-Female,
pubmed-meshheading:12557141-Gene Frequency,
pubmed-meshheading:12557141-Hepacivirus,
pubmed-meshheading:12557141-Hepatitis C, Chronic,
pubmed-meshheading:12557141-Homozygote,
pubmed-meshheading:12557141-Humans,
pubmed-meshheading:12557141-Interferons,
pubmed-meshheading:12557141-Liver Cirrhosis,
pubmed-meshheading:12557141-Male,
pubmed-meshheading:12557141-Middle Aged,
pubmed-meshheading:12557141-Polymorphism, Genetic,
pubmed-meshheading:12557141-Receptors, CCR2,
pubmed-meshheading:12557141-Receptors, CCR5,
pubmed-meshheading:12557141-Receptors, Chemokine,
pubmed-meshheading:12557141-Treatment Outcome,
pubmed-meshheading:12557141-Viral Load
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
|
|
pubmed:affiliation |
The Liver Diseases Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. promrat@nih.gov
|
|
pubmed:publicationType |
Journal Article
|
